Epirubicin and Paclitaxel, Alone or Together With Capecitabine as First Line Treatment in Metastatic Breast Cancer

Clinical trial NCT01433614 · COMPLETED

Trial details

NCT number: NCT01433614
Sponsor: Thomas Hatschek
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Metastatic Breast Cancer

Start date: 2002-12-01
Primary completion: 2006-06-01
Enrollment: 304

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.